143 related articles for article (PubMed ID: 6265549)
1. Potential use of attenuated langat E5 virus as a live vaccine -- long term protection against Russian spring-summer encephalitis virus in mice.
Thind S
J Hyg Epidemiol Microbiol Immunol; 1981; 25(2):155-62. PubMed ID: 6265549
[TBL] [Abstract][Full Text] [Related]
2. Infectious cDNA clone of attenuated Langat tick-borne flavivirus (strain E5) and a 3' deletion mutant constructed from it exhibit decreased neuroinvasiveness in immunodeficient mice.
Pletnev AG
Virology; 2001 Apr; 282(2):288-300. PubMed ID: 11289811
[TBL] [Abstract][Full Text] [Related]
3. A live vaccine against tick-borne encephalitis: integrated studies. I. Basic properties and behaviour of the E5 "14" Clone (Langat virus).
Mayer V
Acta Virol; 1975 May; 19(3):209-18. PubMed ID: 239576
[TBL] [Abstract][Full Text] [Related]
4. [The possibility of preparing a live vaccine against tick-borne encephalitis from Malay langat virus TP-21].
Il'enko VI; Platonov VG; Prozorova IN; Smorodintsev AA
Tr Inst Im Pastera; 1989; 65():126-32. PubMed ID: 2560847
[No Abstract] [Full Text] [Related]
5. Safety evaluation of chimeric Langat/Dengue 4 flavivirus, a live vaccine candidate against tick-borne encephalitis.
Pripuzova NS; Tereshkina NV; Gmyl LV; Dzhivanyan TI; Rumyantsev AA; Romanova LIu; Mustafina AN; Lashkevich VA; Karganova GG
J Med Virol; 2009 Oct; 81(10):1777-85. PubMed ID: 19697399
[TBL] [Abstract][Full Text] [Related]
6. Intranasal immunization with inactivated tick-borne encephalitis virus and the antigenic peptide 89-119 protects mice against intraperitoneal challenge.
Goncharova E; Ryzhikov E; Poryvaev V; Bulychev L; Karpyshev N; Maksyutov A; Ryzhikov AB
Int J Med Microbiol; 2006 May; 296 Suppl 40():195-201. PubMed ID: 16545605
[TBL] [Abstract][Full Text] [Related]
7. Tick-borne Langat/mosquito-borne dengue flavivirus chimera, a candidate live attenuated vaccine for protection against disease caused by members of the tick-borne encephalitis virus complex: evaluation in rhesus monkeys and in mosquitoes.
Pletnev AG; Bray M; Hanley KA; Speicher J; Elkins R
J Virol; 2001 Sep; 75(17):8259-67. PubMed ID: 11483771
[TBL] [Abstract][Full Text] [Related]
8. A live vaccine against tick-borne encephalitis; integrated studies, H. Histopathology of mice peripherally immunized with E5 "14" virus and challenged with virulent virus.
Mitrová E; Mayer V
Acta Virol; 1975 May; 19(3):219-28. PubMed ID: 239577
[TBL] [Abstract][Full Text] [Related]
9. Humoral antibody response in volunteers given the live, highly attenuated "14" clone derived from Langat E5 virus.
Mayer V
Acta Virol; 1973 Jul; 17(4):367. PubMed ID: 4148224
[No Abstract] [Full Text] [Related]
10. Evaluation of tick-borne encephalitis DNA vaccines in monkeys.
Schmaljohn C; Custer D; VanderZanden L; Spik K; Rossi C; Bray M
Virology; 1999 Oct; 263(1):166-74. PubMed ID: 10544091
[TBL] [Abstract][Full Text] [Related]
11. Immunization with recombinant vaccinia viruses expressing structural and part of the nonstructural region of tick-borne encephalitis virus cDNA protect mice against lethal encephalitis.
Dmitriev IP; Khromykh AA; Ignatyev GM; Gainullina MN; Ageenko VA; Dryga SA; Vorobyeva MS; Sandakhchiev LS
J Biotechnol; 1996 Jan; 44(1-3):97-103. PubMed ID: 8717392
[TBL] [Abstract][Full Text] [Related]
12. Long-term persistence of cell-mediated and humoral immune response in specifically resistant mice given live attenuated langat (E5 "14") virus.
Gajdosová E; Mayer V
Acta Virol; 1978 Mar; 22(2):131-8. PubMed ID: 26198
[TBL] [Abstract][Full Text] [Related]
13. A study of systems for delivering antigens and plasmid DNA for intranasal immunization against tick-borne encephalitis virus.
Goncharova EP; Ryzhikov AB; Bulychev LE; Sizov AA; Lebedev LR; Poryvaev VD; Karpenko LI; Il'ichev AA
Wien Klin Wochenschr; 2002 Jul; 114(13-14):630-5. PubMed ID: 12422616
[TBL] [Abstract][Full Text] [Related]
14. A live vaccine against tick-born encephalitis: integrated studies. III. Response of man to a single dose of the E5 "14" clone (Langat virus).
Mayer V; Pogády J; Starek M; Hrbka J
Acta Virol; 1975 May; 19(3):229-36. PubMed ID: 239578
[TBL] [Abstract][Full Text] [Related]
15. Chimeric Langat/Dengue viruses protect mice from heterologous challenge with the highly virulent strains of tick-borne encephalitis virus.
Pletnev AG; Karganova GG; Dzhivanyan TI; Lashkevich VA; Bray M
Virology; 2000 Aug; 274(1):26-31. PubMed ID: 10936085
[TBL] [Abstract][Full Text] [Related]
16. Immunization of mice against Russian spring-summer virus complex and monkeys against Powassan virus with attenuated Langat E5 virus. Duration of protection.
Price WH; Thind IS
Am J Trop Med Hyg; 1973 Jan; 22(1):100-8. PubMed ID: 4630881
[No Abstract] [Full Text] [Related]
17. To the antigenic classification of some viruses from the tick-borne encephalitis complex by monoclonal antibodies.
Gresíková M; Sekeyová M
Acta Virol; 1990 Feb; 34(1):90-4. PubMed ID: 1975730
[TBL] [Abstract][Full Text] [Related]
18. Transfer with dialysable transfer factor of T-lymphocyte cytolytic response to tick-bone encephalitis virus antigen in naive mice.
Mayer V; Gajdosová E; Oravec C
Acta Virol; 1980 Dec; 24(6):459-63. PubMed ID: 6111208
[TBL] [Abstract][Full Text] [Related]
19. Peroral immunization of adult white mice with the Skalica strain from the tick-borne encephalitis virus complex.
Elecková E; Gresíková M
Acta Virol; 1992 Oct; 36(5):466-72. PubMed ID: 1364023
[TBL] [Abstract][Full Text] [Related]
20. Attenuated Langat E5 virus as a live virus vaccine against Kyasanur Forest disease virus.
Thind IS
Indian J Med Res; 1981 Feb; 73():141-9. PubMed ID: 6263797
[No Abstract] [Full Text] [Related]
[Next] [New Search]
